Achord D, Brot F, Gonzalez-Noriega A, Sly W, Stahl P
Pediatr Res. 1977 Jul;11(7):816-22. doi: 10.1203/00006450-197707000-00008.
Human placental beta-glucuronidase could be identified in rat organs by heating organ extracts to 65 degrees which selectively inactivated endogenous rat enzyme. Infused enzyme was rapidly cleared from rat plasma (t0.5 of 3.5 min). From 50-60% of the infused dose was accounted for in rat liver and spleen 24 hr after infusion. Removal of abdominal viscera, including the spleen, and interruption of the portal circulation before infusion slowed the plasma disappearance (t0.5 of 60 min) and allowed significant uptake by bone and other organs. Subcellular fractionation of liver 18 hr postinfusion localized the human enzyme in the mitochondrial-lysosomal fraction. The half-disappearance times of infused human enzyme were 2.6 days in rat liver and 5.8 days in rat spleen. Periodate treatment of human placental beta-glucuronidase destroyed 90% of its binding to concanavalin A-Sephadex rose, reduced its heat stability, and abolished its rapid clearance from rat plasma after infusion.
通过将器官提取物加热至65度,可在大鼠器官中鉴定出人胎盘β-葡萄糖醛酸酶,该温度可选择性地使内源性大鼠酶失活。注入的酶可迅速从大鼠血浆中清除(半衰期为3.5分钟)。注入后24小时,大鼠肝脏和脾脏中占注入剂量的50%-60%。在注入前切除包括脾脏在内的腹部脏器并中断门静脉循环,减缓了血浆清除速度(半衰期为60分钟),并使骨骼和其他器官有明显摄取。注入后18小时对肝脏进行亚细胞分级分离,将人酶定位在线粒体-溶酶体部分。注入的人酶在大鼠肝脏中的半衰期为2.6天,在大鼠脾脏中为5.8天。高碘酸盐处理人胎盘β-葡萄糖醛酸酶破坏了其与伴刀豆球蛋白A-葡聚糖凝胶结合的90%,降低了其热稳定性,并消除了注入后从大鼠血浆中的快速清除。